For instance, a study conducted by Revia et al. discovered that the tumor suppressor KDM6A, a demethylase, can inhibit the progression of HCC by restructuring the epigenetic landscape and influencing mTORC1 signaling in cancer [42]. This evidence concerns the gene MBD2 and hepatocellular carcinoma.